Moderna

Life-saving vaccines targeting serious health conditions including cancer and heart disease could be ready within the next seven years, experts believe. Pharmaceutical company Moderna - which produced one of the leading COVID-19 jabs - is reportedly developing "personalized" vaccines to...

Drugmakers Moderna and Merck said their mRNA cancer vaccine portrayed tremendous results during a preliminary study. During the announcement on Tuesday, the drugmakers said the potential skin cancer vaccine messenger RNA was developed using the same technology behind COVID-19 preventive...

  On Wednesday, the U.S. Food and Drug Administration (FDA) authorized two freshly revised COVID-19 boosters: one created by Moderna and one by Pfizer and German biotechnology company BioNTech. The original SARS-CoV-2 coronavirus variant, which was the target of the first...

Moderna filed patent infringement lawsuits against Pfizer and BioNTech over their mRNA vaccine technology, the company said in a statement.

The Food and Drug Administration on Tuesday authorized a second booster of Pfizer-BioNTech and Moderna for adults 50 years and older, announcing that a fourth shot improves protection against severe Covid-19. The agency also authorized a second Pfizer-BioNTech booster for...

A fourth shot will be needed as the power of the booster wanes, Moderna CEO Stephane Bancel stated on Thursday while addressing a Goldman Sachs healthcare conference. His comments were the first such definitive statement by Moderna regarding the need...

Moderna officials stated on Monday that its booster shot appears to be effective against the Omicron variant of the coronavirus. According to laboratory tests that have been underway, the Moderna shot will continue to be its "first line of defense...

The Centers for Disease Control and Prevention on Thursday recommended the Pfizer and Moderna Covid vaccines over Johnson & Johnson's vaccine. The CDC's advisers pointed to the mounting evidence that the company's vaccine has the potential to set off a...

Existing vaccines may be less effective against the Covid-19 Omicron variant than they are against the other variants out there, the CEO's of Moderna and Pfizer admitted on Monday. Speaking to the Financial Times, the CEO of Moderna warned that...

A so-called "emergency brake" may soon be applied in the fight against the coronavirus as the EU proposes a Southern Africa travel ban because of a new variant that has developed there. The new strain of the virus has a...